StockNews.com Begins Coverage on Ampio Pharmaceuticals (NYSE:AMPE)

Investment analysts at StockNews.com started coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE) in a report issued on Wednesday. The brokerage set a “sell” rating on the stock.

Ampio Pharmaceuticals Price Performance

Shares of NYSE AMPE opened at $0.00 on Wednesday. Ampio Pharmaceuticals has a 1 year low of $0.00 and a 1 year high of $2.91. The firm has a 50-day moving average of $0.01 and a 200 day moving average of $0.03. The stock has a market cap of $2,951.00, a P/E ratio of 0.00 and a beta of 3.67.

Ampio Pharmaceuticals Company Profile

Ampio Pharmaceuticals, Inc, a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.